Dear colleagues:

The Organizing Committee of the “V International Congress on Immunopharmacology” (Immunopharmacology 2020) organized by the Cuban Society of Pharmacology, BioCubaFarma and the International Union of Basic and Clinical Pharmacology (IUPHAR) would like to invite you to participate in this important event, scheduled for June 9 to 13, 2020 at the Convention Centre of the Melia Marina Varadero Hotel, Varadero Beach, Matanzas, Cuba.

The Congress will be formed by different workshops and symposia such as:

• Fifth workshop on new advances in immunopharmacology

• Fifth workshop on neuroimmunology, neuroimmunopharmacology and neuroimmunomodulation. Immunopharmacology of brain tumors

• Symposium on hereditary ataxias

• Fifth symposium on pharmacology of cytochrome P450 and transporters

• Fourth symposium on inflammation and pain

• 2nd symposium on NFkB

• Synthetic peptides as immunopharmacological tools

• Novel designs in clinical trials. Biosimilar pharmaceuticals

• Pharmacogenetics, pharmacogenomics, proteomics and phosphoproteomics

• Immune response in cancer

• First symposium on business and international cooperation on biologics

Immunopharmacology 2020 is sponsored by:

• Cuban Society of Pharmacology (SCF)

• International Union of Basic and Clinical Pharmacology (IUPHAR)

• Latin-American Association of Pharmacology (ALF)

• PAHO / WHO

• BioCubaFarma

• National research centers: Finlay Vaccine Institute (IFV); Center of Genetic Engineering and Biotechnology (CIGB); Center of Molecular Immunology (CIM); Center for Control of Drugs, Equipment and Medical Devices (CECMED); National Center for Animal and Plant Health (CENSA); Tropical Medicine Institute “Pedro Kourí” (IPK); National Center for Biopreparations (BioCEN); Center for Drug Research and Development (CIDEM); Center for Clinical Trials (CENCEC); among others

• International Manufacturers and Companies

The key objectives of the Congress are:

• To provide a progressive state-of-the-art report for scientists, manufacturers, governmental authorities and healthcare workers, who need to be updated about the latest scientific developments for human vaccines, including basic science, product development, market introduction, immunization programs and epidemiological surveillance.

• To promote the scientific collaboration among experts and institutions through the experience exchange, the presentation of results and the discussion on the conference topics.

• To accelerate progress in the development of vaccines and the acceptance and introduction of new methods and technologies.

Opening lectures, oral presentations and posters will provide you the opportunity to be involved in a high quality congress to discuss about the progress in the field of immunology and pharmacology sciences.

Deadline for registration and abstract submission: April 15^th, 2020.

Further information can be found at the website: www.immunovaccipharma.com

We hope to see you in Immunopharmacology 2020.

Author notes

^*E-mail: mlandys@finlay.edu.cu**E-mail: silvio.perea@cigb.edu.cu